Skip to main content

Johnson & Johnson Western Hemisphere, excluding U.S. revenue

  • JNJ · NYSE
  • Healthcare
  • Pharmaceuticals
  • S&P 500
$285.75+0.79%Close 13 Nov 2026 · Market value $684.4B

Western Hemisphere, excluding U.S. revenue at Johnson & Johnson came to $1.4B for the quarter to 27 Sep 2026, up 12.5% from a year earlier.

As Johnson & Johnson reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 21 Oct 2026.

By quarter

$1.2BDec 2023$1.2BMar 2024$1.2BJun 2024$1.2BSep 2024$1.1BDec 2024$1.2BMar 2025$1.2BJun 2025$1.2BSep 2025$1.3BDec 2025$1.3BMar 2026$1.3BJun 2026$1.4BSep 2026
Johnson & Johnson Western Hemisphere, excluding U.S. revenue, every reported period
Period endingWestern Hemisphere, excluding U.S. revenueChange on a yearFiled
27 Sep 2026$1.4Bup 12.5%21 Oct 2026
28 Jun 2026$1.3Bup 8.5%23 Jul 2026
29 Mar 2026$1.3Bup 10.8%22 Apr 2026
28 Dec 2025$1.3Bup 12.0%11 Feb 2026
28 Sep 2025$1.2Bup 4.9%22 Oct 2025
29 Jun 2025$1.2Bdown 0.5%24 Jul 2025
30 Mar 2025$1.2Bdown 2.3%23 Apr 2025
29 Dec 2024$1.1Bdown 2.7%13 Feb 2025
29 Sep 2024$1.2Bup 0.2%23 Oct 2024
30 Jun 2024$1.2Bup 6.7%25 Jul 2024
31 Mar 2024$1.2Bup 11.0%1 May 2024
31 Dec 2023$1.2Bup 13.9%16 Feb 2024
1 Oct 2023$1.2Bup 10.6%27 Oct 2023
2 Jul 2023$1.1Bdown 26.0%31 Jul 2023
2 Apr 2023$1.1Bdown 27.4%28 Apr 2023
1 Jan 2023$1.0Bdown 29.8%16 Feb 2023
2 Oct 2022$1.1Bdown 29.4%27 Oct 2022
3 Jul 2022$1.5Bup 12.4%29 Jul 2022
3 Apr 2022$1.5Bup 4.1%29 Apr 2022
2 Jan 2022$1.5Bup 3.9%17 Feb 2022
3 Oct 2021$1.5Bup 15.7%29 Oct 2021
4 Jul 2021$1.4Bup 20.7%29 Jul 2021
4 Apr 2021$1.4Bdown 5.2%30 Apr 2021
3 Jan 2021$1.4Bdown 6.1%22 Feb 2021
27 Sep 2020$1.3Bdown 12.9%23 Oct 2020
28 Jun 2020$1.1Bdown 22.1%24 Jul 2020
29 Mar 2020$1.5Bdown 0.1%29 Apr 2020
29 Dec 2019$1.5Bup 2.7%18 Feb 2020
29 Sep 2019$1.5Bdown 4.0%28 Oct 2019
30 Jun 2019$1.5Bdown 5.5%29 Jul 2019
31 Mar 2019$1.5Bdown 4.1%1 May 2019
30 Dec 2018$1.5B—20 Feb 2019
30 Sep 2018$1.6Bdown 1.2%31 Oct 2018
1 Jul 2018$1.5B—2 Aug 2018
1 Apr 2018$1.6B—1 May 2018
1 Oct 2017$1.6B—2 Nov 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Johnson & Johnson: MedTech worldwide operational sales (change on a year) · Oncology revenue · Immunology revenue · Neuroscience revenue · Cardiovascular revenue · Pulmonary Hypertension revenue · Cardiovascular/Metabolism/Other revenue · Infectious Diseases revenue · Shockwave revenue · Innovative Medicine revenue · MEDTECH revenue · United States revenue · Non-US revenue · Europe revenue · Asia-Pacific, Africa revenue · financial statements

Every KPI and segment of JNJ, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.